10-Q: Green Planet Bioengineering Q2 2025: Shell Status
Quarterly Report
Green Planet Bioengineering reports continued shell corporation status with no active operations and a significant accumulated deficit, raising going concern doubts.
Summary
- Green Planet Bioengineering Co., Ltd. continues to operate as a public reorganized shell corporation with no active business operations.
- The company's sole purpose is to acquire or merge with an existing business.
- For the six months ended June 30, 2025, the company reported a net loss of $10,945, a reduction from the $17,328 loss in the same period of 2024.
- Administrative expenses decreased to $10,945 for the six months ended June 30, 2025, from $17,328 in the prior year period.
- The company has no cash or current assets.
- Total current liabilities increased to $476,079 as of June 30, 2025, from $465,134 as of December 31, 2024.
- The accumulated deficit grew to $1,105,699 as of June 30, 2025.
- The company's working capital deficit stands at $476,079.
- All cash flow needs are provided by a related party of the majority stockholder, Global Funds Corp.
- An additional $3,500 was advanced by the related party from July 1, 2025, through the filing date.
Sentiment
Score: 2
Explanation: The company is a non-operating shell with significant accumulated deficits and a going concern warning, indicating very high risk and no current value generation. While losses decreased, this is due to minimal activity, not improved operations.
Positives
- Net loss for the six months ended June 30, 2025, decreased to $10,945 from $17,328 in the prior year period.
- Administrative expenses decreased for the six-month period.
- Disclosure controls and procedures were evaluated as effective at a reasonable assurance level.
Negatives
- The company has no active business operations and no revenue.
- It reported a net loss of $10,945 for the six months ended June 30, 2025.
- The company has zero cash and zero current assets.
- Total current liabilities increased to $476,079 as of June 30, 2025.
- The accumulated deficit reached $1,105,699 as of June 30, 2025.
- The company has a working capital deficit of $476,079.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company is entirely dependent on a related party for funding its operating expenses.
Risks
- Ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by the ability to secure adequate financing or find profitable business opportunities.
- Substantial doubt exists about the company's ability to continue as a going concern for a period of twelve months from the issuance date of the filing.
- Delay in effecting business plans will occur if profitable business opportunities are not identified in the near term.
Future Outlook
The company plans to continue sourcing adequate funding from future investors to execute business opportunities when they arise. However, the identification of such funding and profitable business opportunities is entirely dependent on prevailing circumstances, and delays are expected if opportunities are not identified in the near term.
Management Comments
- The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation.
- All of the Company's cash flow needs were provided by a related party of Global Funds, the majority stockholder to pay expenses necessary as a public company.
- Going forward, the Company will continue to source adequate funding from future investors to execute business opportunities when they arise in the future.
Industry Context
This announcement highlights the challenges faced by shell corporations, which exist primarily to facilitate mergers or acquisitions. Their financial health is typically characterized by minimal operations, reliance on external funding (often related parties), and significant accumulated deficits, making them highly speculative investments dependent on future strategic transactions.
Comparison to Industry Standards
- The company's financial state, characterized by zero revenue, zero cash, and a significant accumulated deficit, is typical for a 'shell corporation' or 'blank check company' that has not yet completed its intended business combination.
- Unlike active operating companies, there are no comparable revenue or profit metrics. The primary comparison point for such entities is their ability to secure funding and identify a viable acquisition target, which is currently reliant on a related party.
Related Party Transactions
- The company relies on a related party of the majority stockholder (Global Funds Corp.) to advance funds for operating expenses.
- The amounts advanced, totaling $472,579 as of June 30, 2025, are interest-free, unsecured, and repayable upon demand.
- The company's Chief Executive Officer, Chief Financial Officer, and Director is also a director of the related party.
- An additional $3,500 was advanced by the related party from July 1, 2025, through the filing date.
Stakeholder Impact
- Shareholders: Face significant risk due to the company's shell status, lack of operations, accumulated deficit, and going concern warning. Value is entirely dependent on a future, uncertain business combination.
- Creditors (Related Party): The related party is providing unsecured, interest-free funding, bearing the primary financial risk for the company's continued existence.
Next Steps
- Identify and execute a merger or acquisition with an existing business operation.
- Source adequate funding from future investors.
Key Dates
| Date | Description |
|---|---|
| 2006-10-30 | Mondo Acquisition II, Inc. incorporated in Delaware. |
| 2008-10-02 | Mondo Acquisition II, Inc. changed name to Green Planet Bioengineering Co., Ltd. |
| 2008-10-01 | Company acquired Elevated Throne Overseas Ltd. |
| 2010-04-14 | Elevated Throne Overseas Ltd. and its subsidiaries divested to One Bio, Corp. |
| 2012-03-01 | Company became a subsidiary of Global Fund Holdings Corp. |
| 2024-12-31 | Balance Sheet date for prior fiscal year. |
| 2025-06-30 | End of current quarterly period. |
| 2025-07-01 | Start date for subsequent event related party advance. |
| 2025-08-08 | Date of filing and common stock outstanding count. |
Recommendation
sellThe company is a non-operating shell with no revenue, significant accumulated deficits, and a going concern warning. Its future is entirely dependent on an uncertain acquisition or merger and continued related-party funding. This presents extremely high risk and no fundamental value, making it unsuitable for most investors.
Keywords
Shell corporation, Bioengineering, SEC filing, 10-Q, Financial report, Going concern, Public company, Acquisition target, Merger candidate, Deficit, Related party
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.